. Author manuscript; available in PMC: 2016 Jan 31.

Published in final edited form as: Circ Cardiovasc Genet. 2014 Dec 4;8(1):131–140. doi: 10.1161/CIRCGENETICS.114.000613

Table 3. Association of rs5030062 and rs4253311 with BP in the International Consortium for Blood Pressure Genome-Wide Association Studies;¹⁹ with renal traits in the CKDGen consortium;²¹ and with echocardiographically determined left ventricular mass in the EchoGen Consortium²⁰.

			rs5030062_A		rs4253311_A

Study	Ethnicity	Trait	beta (SE)	p	beta (SE)	P
ICBP¹⁹	European descent	SBP	-0.165 (0.101)	0.10	0.059 (0.097)	0.54
ICBP¹⁹	European descent	DBP	-0.077 (0.064)	0.23	0.082 (0.061)	0.18
EchoGen²⁰	European descent	LV mass	-0.662 (0.444)	0.14	-0.966 (0.440)	0.03
CKDGen²¹	European descent	eGFR	0.0001 (0.001)	0.96	-0.002 (0.001)	0.19
CKDGen²¹	European descent	UACR	0.013 (0.009)	0.16	-0.002 (0.009)	0.80
CKDGen²¹	European descent	CKD	-0.014 (0.022)	0.53	0.023 (0.021)	0.29

LV mass, left ventricular mass, echocardiographically determined; eGFR, estimated glomerular filtration rate, based on serum creatinine measurements; UACR, urinary albumin-to-creatinine ratio; CKD, chronic kidney disease; ICBP, International Consortium for Blood Pressure Genome-Wide Association Studies; SBP, systolic blood pressure; DBP, diastolic blood pressure

Table 3. Association of rs5030062 and rs4253311 with BP in the International Consortium for Blood Pressure Genome-Wide Association Studies;19 with renal traits in the CKDGen consortium;21 and with echocardiographically determined left ventricular mass in the EchoGen Consortium20.

Table 3. Association of rs5030062 and rs4253311 with BP in the International Consortium for Blood Pressure Genome-Wide Association Studies;¹⁹ with renal traits in the CKDGen consortium;²¹ and with echocardiographically determined left ventricular mass in the EchoGen Consortium²⁰.